623 related articles for article (PubMed ID: 31432414)
1. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
[TBL] [Abstract][Full Text] [Related]
2. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
3. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.
Ziganshin RH; Kovalchuk SI; Azarkin IV
Methods Mol Biol; 2019; 2044():111-118. PubMed ID: 31432409
[TBL] [Abstract][Full Text] [Related]
4. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
Anjo SI; Santa C; Manadas B
Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
[TBL] [Abstract][Full Text] [Related]
5. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
6. Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
Hölttä M; Zetterberg H; Mirgorodskaya E; Mattsson N; Blennow K; Gobom J
PLoS One; 2012; 7(8):e42555. PubMed ID: 22880031
[TBL] [Abstract][Full Text] [Related]
7. Intact Protein Analysis by LC-MS for Characterizing Biomarkers in Cerebrospinal Fluid.
Vialaret J; Lehmann S; Hirtz C
Methods Mol Biol; 2019; 1959():163-172. PubMed ID: 30852822
[TBL] [Abstract][Full Text] [Related]
8. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
9. Robust two-dimensional separation of intact proteins for bottom-up tandem mass spectrometry of the human CSF proteome.
Bora A; Anderson C; Bachani M; Nath A; Cotter RJ
J Proteome Res; 2012 Jun; 11(6):3143-9. PubMed ID: 22537003
[TBL] [Abstract][Full Text] [Related]
10. Top Down Proteomics Reveals Mature Proteoforms Expressed in Subcellular Fractions of the Echinococcus granulosus Preadult Stage.
Lorenzatto KR; Kim K; Ntai I; Paludo GP; Camargo de Lima J; Thomas PM; Kelleher NL; Ferreira HB
J Proteome Res; 2015 Nov; 14(11):4805-14. PubMed ID: 26465659
[TBL] [Abstract][Full Text] [Related]
11. Application of 2D-DIGE and iTRAQ Workflows to Analyze CSF in Gliomas.
Rao AA; Mehta K; Gahoi N; Srivastava S
Methods Mol Biol; 2019; 2044():81-110. PubMed ID: 31432408
[TBL] [Abstract][Full Text] [Related]
12. Pressurized pepsin digestion in proteomics: an automatable alternative to trypsin for integrated top-down bottom-up proteomics.
López-Ferrer D; Petritis K; Robinson EW; Hixson KK; Tian Z; Lee JH; Lee SW; Tolić N; Weitz KK; Belov ME; Smith RD; Pasa-Tolić L
Mol Cell Proteomics; 2011 Feb; 10(2):M110.001479. PubMed ID: 20627868
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using
Birke R; Krause E; Schümann M; Blasig IE; Haseloff RF
Methods Mol Biol; 2019; 2044():119-128. PubMed ID: 31432410
[TBL] [Abstract][Full Text] [Related]
14. Improving Proteoform Identifications in Complex Systems Through Integration of Bottom-Up and Top-Down Data.
Schaffer LV; Millikin RJ; Shortreed MR; Scalf M; Smith LM
J Proteome Res; 2020 Aug; 19(8):3510-3517. PubMed ID: 32584579
[TBL] [Abstract][Full Text] [Related]
15. Sample Fractionation Techniques for CSF Peptide Spectral Library Generation.
Pacharra S; Marcus K; May C
Methods Mol Biol; 2019; 2044():69-77. PubMed ID: 31432407
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
17. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
18. Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts.
Ntai I; LeDuc RD; Fellers RT; Erdmann-Gilmore P; Davies SR; Rumsey J; Early BP; Thomas PM; Li S; Compton PD; Ellis MJ; Ruggles KV; Fenyö D; Boja ES; Rodriguez H; Townsend RR; Kelleher NL
Mol Cell Proteomics; 2016 Jan; 15(1):45-56. PubMed ID: 26503891
[TBL] [Abstract][Full Text] [Related]
19. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
[TBL] [Abstract][Full Text] [Related]
20. Low-Molecular-Weight Plasma Proteome Analysis Using Top-Down Mass Spectrometry.
Cheon DH; Yang EG; Lee C; Lee JE
Methods Mol Biol; 2017; 1619():103-117. PubMed ID: 28674880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
